Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Stara Zagora – page 12

164 clinical trials in Stara Zagora, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Stara Zagora at a glance
164
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

164 trials in Stara Zagora

Open in trial search
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Asthma

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Bipolar disorder

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.

Cardiac failure

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azilsartan Medoxomil
  • Sponsor:Novartis Pharma AG

Chronic kidney disease+1

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Alopecia areata

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Emraclidine
  • Sponsor:Cerevel Therapeutics LLC
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Stara Zagora

What the registry says about research in the country

01 Inflammatory Conditions

Clinical trials focusing on inflammatory disorders are evaluating novel treatments for conditions including psoriatic arthritis and hidradenitis suppurativa. Researchers are testing innovative therapies targeting specific inflammatory pathways.

  • Psoriatic Arthritis Studies
  • Hidradenitis Suppurativa Research
  • Chronic Rhinosinusitis Treatments

These studies aim to improve quality of life for patients with chronic inflammatory conditions.

02 Respiratory Medicine

Research in respiratory diseases includes multiple trials investigating new treatments for asthma. Studies are examining both established and experimental medications to enhance breathing function and disease control.

  • Asthma Management
  • Respiratory Function Studies
  • Airway Inflammation Research

Emphasis is placed on developing treatments for moderate to severe cases.

03 Oncology and Hematology

Groundbreaking research in blood cancers and solid tumors includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and prostate cancer. Novel therapeutic approaches are being evaluated.

  • Leukemia Treatments
  • Prostate Cancer Therapy
  • Blood Disorder Management

These trials aim to improve survival rates and treatment outcomes.

04 Neurological Conditions

Studies in neurological disorders are investigating treatments for epilepsy and examining extended-release formulations of existing medications to improve seizure control.

  • Epilepsy Management
  • Seizure Control Studies
  • Drug-Resistant Epilepsy Research

Focus is on developing more effective treatment options for patients with refractory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.